Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial [Phase 2, Phase 3]
A randomized, double-blind, placebo-controlled pilot trial evaluated TNF-alpha antagonists for acute exacerbations of COPD (Phase 2/3); the …
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Effects of Inhaled Corticosteroids on Sputum Bacterial Load in COPD [NA]
This completed clinical trial evaluated the effects of inhaled corticosteroids on sputum bacterial load in chronic obstructive pulmonary dis…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Respiratory and Cardiovascular Effects in COPD [NA]
This clinical trial update reports the completion of a study evaluating respiratory and cardiovascular effects in chronic obstructive pulmon…
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With COPD. [Phase 3]
Phase 3 randomized, double-blind, placebo-controlled cross-over trial assessing three weeks of QVA149 (indacaterol/glycopyrronium) vs placeb…
-
CLINICAL_TRIALS research · 2016-04-05Clinical Trial Update: Phenotypes of COPD in Central and Eastern Europe
Clinical trial update on phenotypes of Chronic Obstructive Pulmonary Disease in Central and Eastern Europe from a completed study. The spons…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy
This clinical trial update reports results of a completed study evaluating changes in physical functioning in patients with chronic obstruct…
-
CLINICAL_TRIALS research · 2016-04-01Clinical Trial Update: Registry of Patients With Acute Dyspnea in the Emergency Department
A completed registry study of patients presenting with acute dyspnea in the emergency department, focusing on heart failure and COPD.
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Non-interventional Study of Spirometry Use to Diagnose COPD (Chronic Obstructive Pulmonary Disease) and to Prescribe Treatment to COPD Patients in the Outpatient Institutions
AstraZeneca-sponsored non-interventional study evaluating spirometry-based diagnosis of chronic obstructive pulmonary disease and how it inf…
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Impact of Feedback on Physical Activity and Health-related Outcomes During Pulmonary Rehabilitation in COPD [NA]
This entry notes that the clinical trial NCT02725931 evaluating feedback on physical activity during pulmonary rehabilitation in COPD has co…
-
CLINICAL_TRIALS withdrawal · 2016-04-01Clinical Trial Update: The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD) [NA]
The PALP™-COPD trial evaluating low-flow CO2 removal (ECCO2-R) in exacerbated COPD has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 dose-ranging study of glycopyrronium bromide in moderate-to-severe chronic obstructive pulmonary disease has completed enrollment an…
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation [Phase 3]
Phase 3 study evaluating safety of the inhaled COPD therapy QVA149 versus QAB149 over 52 weeks; the trial is completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: To Assess the Safety, Tolerability, and Pharmacokinetics of AZD7624 in Healthy Volunteers and COPD Patients [Phase 1]
This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of AZD7624 in healthy volunteers and patients with chronic obstr…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Alpha1-antitrypsin Deficiency Registry
A completed NHLBI-sponsored clinical trial registry update for Alpha-1 antitrypsin deficiency and related lung diseases such as emphysema an…
-
FDA approval · 2016-03-24FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Ipratropium Bromide and Albuterol Sulfate from Cipla USA Inc., indicating approval of a suppleme…
-
FDA approval · 2016-03-24FDA Approved: TUDORZA PRESSAIR — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Tudorza Pressair (aclidinium bromide) submitted by Covis Pharma US, Inc.
-
FDA approval · 2016-03-24FDA Approved: LEVALBUTEROL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for levalbuterol, confirming approval of the generic product under an ANDA and enabling continu…
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: A Safety, Tolerability and Efficacy Study in Chronic Obstructive Pulmonary Disease (COPD) Patients With QBM076. [Phase 2]
Novartis conducted a Phase 2 trial of QBM076 in chronic obstructive pulmonary disease to assess safety, tolerability, and efficacy; the stud…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Outlook Quality of Life Intervention [NA]
This clinical trial update indicates that results have been posted after completion for an outlook quality-of-life intervention, involving c…
-
FDA approval · 2016-03-22FDA Approved: LEVALBUTEROL — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan's original ANDA for levalbuterol hydrochloride, a generic inhaled bronchodilator indicated for reversible obstructive air…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Mindfulness Based Stress Reduction in COPD [Phase 1]
The document reports a completed Phase 1 clinical trial evaluating Mindfulness Based Stress Reduction as an intervention for Chronic Obstruc…
-
FDA approval · 2016-03-18FDA Approved: STIOLTO RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for STIOLTO RESPIMAT, a fixed-dose inhaled combination of tiotropium and olodaterol, submitted by Bo…
-
EMA safety_alert · 2016-03-18PRAC reviews known risk of pneumonia with inhaled corticosteroids for chronic obstructive pulmonary disease
The PRAC is reviewing the known risk of pneumonia associated with inhaled corticosteroids in chronic obstructive pulmonary disease patients.
-
FDA approval · 2016-03-16FDA Approved: TUDORZA PRESSAIR — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for TUDORZA PRESSAIR (aclidinium bromide) submitted by Covis Pharma US, Inc.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Long Term Safety Study of NVA237 vs QAB149 in COPD Patients [Phase 3]
Phase 3 long-term safety trial comparing NVA237 with QAB149 in COPD patients has completed and results were posted.